BEAM BEAM THERAPEUTICS INC Management Changes 8-K Filing 2024 - Management Change Beam Therapeutics appointed Sravan K. Emany as Chief Financial Officer, effective December 19, 2024, with a base salary of $575,000 and a sign-on bonus of $325,000, along with stock options and restricted stock units.Get access to all SEC 8-K filings of the BEAM THERAPEUTICS INC